AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Detalles Bibliográficos
Autores principales: Marsilio, I., Maniero, D., Lorenzon, G., Rigo, A., Cardin, R., Facchin, S., Barberio, B., D’Incà, R., Zingone, F., Bahur, B., Bray, K., Savarino, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. 2021
Materias:
Abstracts of the 27th National Congress of Digestive Diseases 2021 – FISMAD
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451193/
http://dx.doi.org/10.1016/S1590-8658(21)00611-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451193/
http://dx.doi.org/10.1016/S1590-8658(21)00611-3

Ejemplares similares